Key points are not available for this paper at this time.
Abstract Objective: The main objective of the study was to compare neonatal outcomes; the incidence of NOWS, length of hospital stay (LOS), admission to neonatal intensive care (NICU), treatment with morphine and head circumference between newborns of mothers who had tapering of buprenorphine (T group) during pregnancy to non-tapering of buprenorphine (NT group. Study Design: It was a prospective, pilot, case-control trial of pregnant women done in North-East Tennessee in pregnancy with opioid use disorder (OUD) in tapered (T) group as a part of clinical contract while NT group did not taper medication. Results: Significant differences observed in maternal buprenorphine doses, 1.47 versus 7.6 (p p p Conclusion: Comprehensive outpatient buprenorphine tapering can be done in OUD pregnancy with improved neonatal outcomes.
Shah et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: